MCCP
TMO icon

Mission Creek Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Mission Creek Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Buy
4,217
+62
+1% +$29.8K 0.37% 70
2026
Q1 		$2.04M Buy
4,155
+1,565
+60% +$849K 0.41% 64
2025
Q4 		$1.5M Buy
2,590
+161
+7% +$91K 0.3% 85
2025
Q3 		$1.18M Buy
2,429
+13
+0.5% +$6.05K 0.23% 95
2025
Q2 		$980K Sell
2,416
-513
-18% -$214K 0.22% 96
2025
Q1 		$1.46M Sell
2,929
-527
-15% -$285K 0.35% 79
2024
Q4 		$1.8M Buy
3,456
+43
+1% +$23.6K 0.39% 71
2024
Q3 		$2.11M Buy
3,413
+55
+2% +$32.6K 0.49% 61
2024
Q2 		$1.86M Buy
3,358
+1,504
+81% +$862K 0.47% 59
2024
Q1 		$1.08M Buy
1,854
+759
+69% +$426K 0.28% 99
2023
Q4 		$581K Sell
1,095
-5
-0.5% -$2.42K 0.15% 144
2023
Q3 		$557K Sell
1,100
-116
-10% -$61.8K 0.19% 140
2023
Q2 		$634K Sell
1,216
-6
-0.5% -$3.24K 0.2% 136
2023
Q1 		$704K Hold
1,222
– – 0.24% 123
2022
Q4 		$673K Sell
1,222
-66
-5% -$35K 0.24% 120
2022
Q3 		$653K Sell
1,288
-25
-2% -$14K 0.25% 117
2022
Q2 		$713K Sell
1,313
-20
-2% -$11K 0.24% 120
2022
Q1 		$787K Sell
1,333
-10
-0.7% -$5.74K 0.21% 132
2021
Q4 		$896K Sell
1,343
-102
-7% -$63.7K 0.18% 139
2021
Q3 		$826K Sell
1,445
-145
-9% -$79.6K 0.15% 139
2021
Q2 		$802K Hold
1,590
– – 0.13% 130
2021
Q1 		$726K Sell
1,590
-150
-9% -$71.6K 0.11% 130
2020
Q4 		$810K Hold
1,740
– – 0.25% 109
2020
Q3 		$768K Hold
1,740
– – 0.3% 97
2020
Q2 		$630K Hold
1,740
– – 0.33% 81
2020
Q1 		$493K Buy
1,740
+70
+4% +$22.1K 0.26% 88
2019
Q4 		$543K Buy
+1,670
New +$506K 0.25% 106

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mission Creek Capital Partners's TMO Position: Q2 2026 in Review

Mission Creek Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2026, buying an estimated $29.8K and bringing the position to 4,217 shares worth $2.11M. The position accounts for 0.37% of the portfolio, ranked #70.

Mission Creek Capital Partners first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. 2,626 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Mission Creek Capital Partners held 4,217 shares of Thermo Fisher Scientific worth $2.11M as of Q2 2026.
  • Mission Creek Capital Partners bought 62 Thermo Fisher Scientific shares in Q2 2026, an estimated $29.8K.
  • Thermo Fisher Scientific made up 0.37% of Mission Creek Capital Partners's portfolio in Q2 2026, its #70 holding.
  • Mission Creek Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • 2,626 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Mission Creek Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.